Clinical Trials Browser

Suspended × spartalizumab × 1 year × Clear all

NCT07403136 2026-04-15

Vebrekotuzumab ± Anti-PD-1 in Pretreated Advanced ESCC

Phase 2 Suspended

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT06728657 2025-06-18

TORCH-G

Phase 2 Suspended

Gastrointestinal

Stomach Adenocarcinoma